Abstract
A significant percentage of non-small cell lung cancer (NSCLC) patients could not achieve major pathologic response (MPR) through the neoadjuvant immunotherapy. This study, based on multicenter cohorts, purposes to utilize CT images to construct and validate a deep learning model for predicting MPR of NSCLC patients treated by neoadjuvant immunotherapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
